[Molecular pharmacology on intracellular calcium messenger system].
D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D000205:Actomyosin / Q000378:metabolism; D001665:Binding Sites; D002118:Calcium / Q000378:metabolism / Q000502:physiology*; D002121:Calcium Channel Blockers / Q000378:metabolism / Q000494:pharmacology; D002147:Calmodulin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002148:Calmodulin-Binding Proteins / Q000378:metabolism; D005110:Extracellular Space / Q000378:metabolism; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D010770:Phosphotransferases / Q000502:physiology; D010879:Piperazines / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology
D002121:Calcium Channel Blockers; D002147:Calmodulin; D002148:Calmodulin-Binding Proteins; D007546:Isoquinolines; D010879:Piperazines; D013449:Sulfonamides; C017967:W 7; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; D000205:Actomyosin; C043204:N-(2-guanidinoethyl)-5-isoquinolinesulfonamide; D010770:Phosphotransferases; D002118:Calcium